Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
Gliomas are among the most aggressive malignant tumors and the most refractory to therapy, in part due to the propensity for malignant cells to disseminate diffusely throughout the brain. Here, we have used 27 K cDNA microarrays to investigate global gene expression changes between normal brain and high-grade glioma (glioblastoma multiforme) to try and better understand gliomagenesis and to identify new therapeutic targets. We have also included smaller groups of grade II and grade III tumors of mixed astrocytic and oligodendroglial origin as comparison. We found that the expression of hundreds of genes was significantly correlated to each group, and employed a naïve Bayesian classifier with leave-one-out cross-validation to accurately classify the samples. We developed a novel algorithm to analyze the gene expression data from the perspective of chromosomal position, and identified distinct regions of the genome that displayed coordinated expression patterns that correlated significantly to tumor grade. The regions identified corresponded to previously known genetic copy number changes in glioma (e.g. 10q23, 10q25, 7q, 7p) as well as regions not previously associated significantly with glioma (e.g. 1p13, 6p22). Furthermore, to enrich for more suitable targets for therapy, we took a bioinformatics approach and annotated our signatures with two published datasets that identified membrane/secreted genes from cytosolic genes. The resulting focused list of 31 genes included interesting novel potential targets as well as several proteins already being investigated for immunotherapy (e.g. CD44 and tenascin-C). Software for the chromosome analysis was developed and is freely available at http://base.thep.lu.se.
Persson
Oscar
O
Department of Neurosurgery, The Rausing Laboratory, Lund University, 22100 Lund, Sweden.
Krogh
Morten
M
Saal
Lao H
LH
Englund
Elisabet
E
Liu
Jian
J
Parsons
Ramon
R
Mandahl
Nils
N
Borg
Ake
A
Widegren
Bengt
B
Salford
Leif G
LG
D000465:Algorithms; D014408:Biomarkers, Tumor; D001932:Brain Neoplasms / Q000145:classification / Q000235:genetics* / Q000628:therapy*; D002875:Chromosomes / Q000235:genetics* / Q000648:ultrastructure*; D016000:Cluster Analysis; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D016503:Drug Delivery Systems; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics / Q000502:physiology; D052138:Genes, Neoplasm / Q000235:genetics*; D005910:Glioma / Q000145:classification / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D017403:In Situ Hybridization; D015233:Models, Statistical; D020411:Oligonucleotide Array Sequence Analysis; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D018076:DNA, Complementary; D004273:DNA, Neoplasm